• DOI:10.1016/S0920-9964(02)00434-6
Corpus ID: 32114191

Nerve growth factor in never-medicated first-episode psychotic and medicated chronic schizophrenic patients: possible implications for treatment outcome

@article{Parikh2003NerveGF,
  title={Nerve growth factor in never-medicated first-episode psychotic and medicated chronic schizophrenic patients: possible implications for treatment outcome},
  author={V. Parikh and D. R. Evans and M. Khan and S. Mahadik},
  journal={Schizophrenia Research},
  year={2003},
  volume={60},
  pages={117-123}
}

V. Parikh, D. R. Evans, +1 author S. Mahadik

Published 2003

Psychology, Medicine

Schizophrenia Research

Nerve growth factor (NGF) has been found to play a crucial role in the neuroplasticity of predominantly cholinergic neurons in brain development, and neuronal survival following brain injury, which reflect in cognitive performance. Wide ranges of neurodevelopmental abnormalities have been reported in schizophrenic patients, who also show poor cognitive performance. We report plasma NGF levels in never-medicated first-episode psychotic (FEP; N=24) and chronic medicated schizophrenic patients (N… CONTINUE READING

View on Elsevier

doi.org

Save to Library

Create Alert

Cite

Launch Research Feed